Combined Fungal Composition for Modulating Inflammatory Response
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 63/004,788, filed Apr 3, 2020. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,730,784 | Compositions and Methods for Modulating Inflammatory Response In force · High confidence | Turtle Bear Holdings, LLC | In force | High confidence | ||
| US 11,779,620 | Combined Fungal Composition for Modulating Inflammatory Response In force · High confidence | Turtle Bear Holdings, LLC | In force | High confidence | ||
| US 12,622,938 | Compositions and Methods for Modulating Inflammatory Response In force · High confidence | Turtle Bear Holdings, LLC | In force | High confidence | ||
| US 12,622,940 | Combined Fungal Composition for Modulating an Inflammatory Response In force · High confidence | Turtle Bear Holdings, LLC | In force | High confidence | ||
| Application 19/641,242 | Combined Fungal Composition for Modulating an Inflammatory Response Pending Not granted | Turtle Bear Holdings, LLC | Pending | Not granted | ||
| Application 19/644,684 | Compositions and Methods for Modulating Inflammatory Response Pending Not granted | Turtle Bear Holdings, LLC | Pending | Not granted |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Turtle Bear Holdings, LLC.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.